The Trump administration's claim linking acetaminophen to autism is facing strong criticism. Colin Killick of the Autistic Self Advocacy Network denounced the statement, arguing it promotes stigma and blames parents. Scientific groups reject the administration's assertions, lacking research support. Killick expressed concern over the administration's focus on reducing autism rates, fearing it marginalizes autistic individuals. The administration defended its actions, highlighting its commitment to addressing parental concerns and pursuing scientific inquiry.

Prepared by Lauren Mitchell and reviewed by editorial team.